Multifunctional gold-nanoparticles: A nanovectorization tool for the targeted delivery of novel chemotherapeutic agents

Journal of Controlled Release

Volumn 245, Issue , 2017, Pages 52-61

  Fernandes, Alexandra R ^a,b   Jesus, João ^a   Martins, Pedro ^a   Figueiredo, Sara ^a   Rosa, Daniela ^a   Martins, Luísa M R D R S ^b,c   Corvo, Maria Luísa ^d   Carvalheiro, Manuela C ^d   Costa, Pedro M ^a   Baptista, Pedro V ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^c INSTITUTO SUPERIOR DE ENGENHARIA DE LISBOA   (Portugal)

^d RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Cancer therapy; Colorectal cancer; Gold nanoparticles; Lung cancer; Metal complexes; Nanomedicine; Targeting

Indexed keywords

ANTIBODIES; BIOLOGICAL MATERIALS; CELLS; COBALT COMPOUNDS; CYTOTOXICITY; DISEASES; FIBER OPTIC SENSORS; GOLD; GOLD COMPOUNDS; MEDICAL NANOTECHNOLOGY; METAL COMPLEXES; MONOCLONAL ANTIBODIES; NANOPARTICLES; TUMORS;

CANCER THERAPY; COLORECTAL CANCER; GOLD NANOPARTICLES; LUNG CANCER; TARGETING;

METAL NANOPARTICLES;

1,10 PHENANTHROLINE; ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; COBALT COMPLEX; COORDINATION COMPOUND; EPIDERMAL GROWTH FACTOR RECEPTOR; GOLD NANOPARTICLE; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY; NANOCONJUGATE; PACLITAXEL; COBALT; DRUG CARRIER; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER MODEL; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULARY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FIBROBLAST; NEOPLASM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; COBALT; COORDINATION COMPLEXES; DRUG CARRIERS; FIBROBLASTS; GOLD; HUMANS; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED NOD; MICE, SCID; NANOCONJUGATES; NEOPLASMS; PACLITAXEL; POLYETHYLENE GLYCOLS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SERUM ALBUMIN; TUMOR BURDEN;

EID: 84999008906     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.11.021     Document Type: Article

References (29)

1. [1] Wicki, A., Witzigmann, D., Balasubramanian, V., Huwyler, J., Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J. Control. Release 200 (2015), 138–157.
2. [2] Bao, G., Mitragotri, S., Tong, S., Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng. 15 (2013), 253–282.
3. [3] Cabral, R.M., Baptista, P.V., Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles. Expert. Rev. Mol. Diagn. 14 (2014), 1041–1052.
4. [4] Bao, C., Conde, J., Polo, E., del Pino, P., Moros, M., Baptista, P.V., Grazu, V., Cui, D., de la Fuente, J.M., A promising road with challenges: where are gold nanoparticles in translational research?. Nanomedicine (Lond). 9 (2014), 2353–2370.
5. [5] Peer, D., Karp, J.M., Hong, S., Farokhzad, O.C., Margalit, R., Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2 (2007), 751–760.
6. [6] Khawar, I.A., Kim, J.H., Kuh, H.J., Improving drug delivery to solid tumors: priming the tumor microenvironment. J. Control. Release 201 (2015), 78–89.
7. [7] Pérez-Herrero, E., Fernández-Medarde, A., Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur. J. Pharm. Biopharm. 93 (2015), 52–79.
8. [8] Dreaden, E.C., Austin, L.A., Mackey, M.A., El-Sayed, M.A., Size matters: gold nanoparticles in targeted cancer drug delivery. Ther. Deliv. 3 (2012), 457–478.
9. [9] Conde, J., Ambrosone, A., Sanz, V., Hernandez, Y., Marchesano, V., Tian, F., Child, H., Berry, C.C., Ibarra, M.R., Baptista, P.V., et al. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing. ACS Nano 6 (2012), 8316–8324.
10. [10] Lin, G., Mi, P., Chu, C., Zhang, J., Liu, G., Inorganic nanocarriers overcoming multidrug resistance for cancer theranostics. Adv. Sci., 2016, 10.1002/advs.201600134.
11. [11] Conde, J., Rosa, J., de la Fuente, J.M., Baptista, P.V., Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials 34 (2013), 2516–2523.
12. [12] Conde, J., Larguinho, M., Cordeiro, A., Raposo, L.R., Costa, P.M., Santos, S., Diniz, M.S., Fernandes, A.R., Baptista, P.V., Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis. Nanotoxicology 8 (2014), 521–532.
13. [13] Conde, J., Oliva, N., Artzi, N., Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E1278–E1287.
14. [14] Torchilin, V.P., Rammohan, R., Weissig, V., Levchenko, T.S., TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 8786–8791.
15. [15] Kumar, A., Ma, H., Zhang, X., Huang, K., Jin, S., Liu, J., Wei, T., Cao, W., Zou, G., Liang, X.J., Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials 33 (2012), 1180–1189.
16. [16] Yu, M.K., Park, J., Jon, S., Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2 (2012), 3–44.
17. [17] Beddoes, C.M., Case, C.P., Briscoe, W.H., Understanding nanoparticle cellular entry: a physicochemical perspective. Adv. Colloid Interf. Sci. 218 (2015), 48–68.
18. [18] Stern, S.T., Adiseshaiah, P.P., Crist, R.M., Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part. Fibre Toxicol., 9, 2012, 20.
19. [19] Spadavecchia, J., Movia, D., Moore, C., Maguire, C.M., Moustaoui, H., Casale, S., Volkov, Y., Prina-Mello, A., Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies. Int. J. Nanomedicine 11 (2016), 791–822.
20. [20] Waheed, A., Gupta, A., Patel, P., Targeted drug delivery systems for pancreatic cancer. PharmaTutor Mag. 3 (2015), 3462–3482.
21. [21] Mendes, R., Carreira, B., Baptista, P.V., Fernandes, A.R., Non-small cell lung cancer biomarkers and targeted therapy - two faces of the same coin fostered by nanotechnology. Expert Ver. Precis. Med. Drug Dev. 1 (2016), 155–168.
22. [22] Silva, T.F.S., Smoleński, P., Martins, L.M.D.R.S., Guedes da Silva, M.F.C., Fernandes, A.R., Luis, D., Silva, A., Santos, S., Borralho, P.M., Rodrigues, C.M.P., et al. Cobalt and zinc compounds bearing 1,10-phenanthroline-5,6-dione or 1,3,5-triaza-7-phosphaadamantane derivatives - synthesis, characterization, cytotoxicity, and cell selectivity studies. Eur. J. Inorg. Chem. 2013 (2013), 3651–3658.
23. [23] Silva, A., Luis, D., Santos, S., Silva, J., Mendo, A.S., Coito, L., Silva, T.F., da Silva, M.F., Martins, L.M., Pombeiro, A.J., Borralho, P.M., Rodrigues, C.M., Cabral, M.G., Videira, P.A., Monteiro, C., Fernandes, A.R., Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach. Drug Metabol. Drug Interact. 28 (2013), 167–176.
24. [24] Luís, D.V., Silva, J., Tomaz, A.I., de Almeida, R.F.M., Larguinho, M., Baptista, P.V., Martins, L.M.D.R.S., Silva, T.F.S., Borralho, P.M., Rodrigues, C.M.P., Rodrigues, A.S., Pombeiro, A.J., Fernandes, A.R., Insights into the mechanisms underlying the anti-proliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies. J. Biol. Inorg. Chem. 19 (2014), 787–803.
25. [25] Lee, C., Meisel, D., Adsorption and surface-enhanced Raman of dyes on silver and gold sols. J. Phys. Chem. 86 (1982), 3391–3395.
26. [26] Costa, P.M., Costa, M.H., Development and application of a novel histological multichrome technique for clam histopathology. J. Invertebr. Pathol. 110 (2012), 411–414.
27. [27] Li, Y., He, W.Y., Liu, J.Q., Sheng, F.L., Hu, Z.D., Chen, X.G., Biochim. Biophys. Acta 1722 (2005), 15–21.
28. [28] Yang, F., Zhang, Y., Liang, H., Interactive association of drugs binding to human serum albumin. Int. J. Mol. Sci. 15 (2014), 3580–3595.
29. [29] Bi, S., Sunb, Y., Qiao, C., Zhang, H., Liu, C., Binding of several anti-tumor drugs to bovine serum albumin: fluorescence study. J. Lumin. 129 (2009), 541–547.